kaken pharmaceutical co ltd
(4521:Tokyo Stock Exchange)
Executive Profile*
Takao EndoHead of General Affairs and Executive Director, Kaken Pharmaceutical Co. Ltd. |
| Age | Total Calculated Compensation | This person is connected to 34 board members in 3 different organizations across 3 different industries. See Board Relationships |
| -- | -- |
Background*
Mr. Takao Endo has been Chief Executive Officer and President at Oracle Corporation Japan, since June 2008 and its Representative Executive Officer since August 2008. Mr. Endo has been Senior Vice President of Oracle Corporation since June 2008. Mr. Endo serves as Head of General Affairs and Executive Director at Kaken Pharmaceutical Co. Ltd. He Joined IBM Japan, Ltd. in April 1977 and served as its Director and Manager, Industrial Service Business Department since March ...
Corporate Headquarters*28-8, Honkomagome 2-chomeTokyo, Tokyo 113-8650 Japan Phone: 81 3 5977 5001 Fax: 81 3 5977 5131 Board Members Memberships*Head of General Affairs and Executive Director 2008-Present Chief Executive Officer, President, Director, Member of Compensation Committee and Member of Nominating Committee
Education*Unknown/Other Education Tokyo University of Science
Other Affiliations* |
Annual Compensation*There is no Annual Compensation data available.Stock Options*There is no Stock Options data available.Total Compensation*There is no Total Compensation data available. |
| Recently Viewed | |||
| 4521:JP | ¥1,736.00 JPY | +31.00 | |
COMPETITOR COMPENSATION
| There is no Competitor Compensation data available. |
Post a JobJobs
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
- New York, NY | New York UniversityPosted: Apr 19
Sponsored Financial Commentaries
Sponsored Links
To contact KAKEN PHARMACEUTICAL CO LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








